Athira Pharma, Inc.
ATHA
$0.36
$0.01885.51%
NASDAQ
03/31/2025 | 12/31/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | -15.53% | -18.17% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -38.74% | -38.94% | |||
Operating Income | 38.74% | 38.94% | |||
Income Before Tax | 39.06% | 47.80% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | 39.06% | 47.80% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 39.06% | 47.80% | |||
EBIT | 38.74% | 38.94% | |||
EBITDA | 39.35% | 39.32% | |||
EPS Basic | 39.58% | 48.06% | |||
Normalized Basic EPS | 39.27% | 39.23% | |||
EPS Diluted | 39.58% | 48.06% | |||
Normalized Diluted EPS | 39.27% | 39.23% | |||
Average Basic Shares Outstanding | 0.88% | 0.48% | |||
Average Diluted Shares Outstanding | 0.88% | 0.48% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |